CASI PHARMACEUTICALS, INC. Form 20-F: Annual report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-05-15: Form 20-F; Period of report 2025-12-31; Description 20-F; Document casif-20251231x20f.htm.
- 2025-03-31: Form 20-F; Period of report 2024-12-31; Description 20-F; Document casi-20241231x20f.htm.
- 2024-03-28: Form 20-F; Period of report 2023-12-31; Description 20-F; Document casi-20231231x20f.htm.
- 2023-04-26: Form 20-F; Period of report 2022-12-31; Description 20-F; Document casi-20221231x20f.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-05-15 | 20-F | 2025-12-31 | 20-F | casif-20251231x20f.htm |
| 2025-03-31 | 20-F | 2024-12-31 | 20-F | casi-20241231x20f.htm |
| 2024-03-28 | 20-F | 2023-12-31 | 20-F | casi-20231231x20f.htm |
| 2023-04-26 | 20-F | 2022-12-31 | 20-F | casi-20221231x20f.htm |